We tried to express the eight antimicrobial peptides in E. coli. These composite parts contains the coding sequence, RBS, a T7 promoter, and also intein and CBD sequences for better purification.
The other composite part contains each basic part from NCTU_Formosa 2016. We found this peptide also shows its ability to inhibit Bacillus subtilis.
Line 53: | Line 53: | ||
.text{ | .text{ | ||
− | font-size: | + | font-size: 3vmin; |
− | width: | + | width: 70%; |
position: relative; | position: relative; | ||
− | margin-left: | + | margin-left: 15%; |
margin-top: 40px; | margin-top: 40px; | ||
margin-bottom: 40px; | margin-bottom: 40px; | ||
Line 85: | Line 85: | ||
transition-duration: 0.4s; | transition-duration: 0.4s; | ||
position: relative; | position: relative; | ||
− | left: | + | left: 15%; |
margin: 30px; | margin: 30px; | ||
} | } | ||
Line 112: | Line 112: | ||
} | } | ||
− | |||
− | |||
− | |||
.part_button { | .part_button { | ||
Line 175: | Line 172: | ||
<div class="sec1"> | <div class="sec1"> | ||
<img src="https://static.igem.org/mediawiki/2018/f/f8/T--NCTU_Formosa--Composite_parts.png" class="basic_title"> | <img src="https://static.igem.org/mediawiki/2018/f/f8/T--NCTU_Formosa--Composite_parts.png" class="basic_title"> | ||
− | |||
− | |||
<div class="text"> | <div class="text"> | ||
<p> | <p> | ||
Line 207: | Line 202: | ||
<div class="title_1"><p>Improvement</p></div> | <div class="title_1"><p>Improvement</p></div> | ||
</div> | </div> | ||
− | |||
− | |||
− | |||
</div> | </div> |
Revision as of 11:10, 13 October 2018
![](https://static.igem.org/mediawiki/2018/f/ff/T--NCTU_Formosa--Navigation.png)
![](https://static.igem.org/mediawiki/2018/f/f8/T--NCTU_Formosa--Composite_parts.png)
Bacteriocins
Subtilosin-Intein-CBD(BBa_K2599008)
![](https://static.igem.org/mediawiki/2018/b/bf/T--NCTU_Formosa--Sub_2.png)
Bovicin HJ50-Intein-CBD(BBa_K2599009)
![](https://static.igem.org/mediawiki/2018/f/f5/T--NCTU_Formosa--Bov_2.png)
Enterocin A-Intein-CBD(BBa_K2599010)
![](https://static.igem.org/mediawiki/2018/4/45/T--NCTU_Formosa--Ent_A_2.png)
Enterocin B-Intein-CBD(BBa_K2599011)
![](https://static.igem.org/mediawiki/2018/5/5f/T--NCTU_Formosa--Ent_B_2.png)
Enterocin 96-Intein-CBD(BBa_K2599012)
![](https://static.igem.org/mediawiki/2018/d/da/T--NCTU_Formosa--Ent_96_2.png)
Lacticin Z-Intein-CBD(BBa_K2599013)
![](https://static.igem.org/mediawiki/2018/8/8b/T--NCTU_Formosa--Lac_2.png)
Leucocyclicin Q-Intein-CBD(BBa_K2599014)
![](https://static.igem.org/mediawiki/2018/1/13/T--NCTU_Formosa--Leu_2.png)
Durancin TW-49M-Intein-CBD(BBa_K2599015)
![](https://static.igem.org/mediawiki/2018/b/b4/T--NCTU_Formosa--Dur_2.png)
Improvement